Bài tổng quan hệ thống: Ý nghĩa và khả năng áp dụng của kết quả từ các đánh giá kinh tế y tế về thay van động mạch chủ qua da

Baumgartner H, Falk V, Bax JJ, et al. The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;38(36):2739–91. Vahanian A, Alfieri O, Andreotti F. Guidelines on the Management of Valvular Heart Disease (version 2012): the Joint Task Force on the Managment of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;33(19):2451–96. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circ J. 1982;66(5):1105–10. Schuchlenz H. Evaluierung der valvulären Aortenstenose: ein kritischer Vergleich nicht invasiver echokardiographischer und invasiver. Diagnostik J Für Kardiologie. 1999;6(1):18–20. Faggiano P, Antonini-Canterin F, Baldessin F, et al. Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound. Acta Neurochir (Wien). 2006;4:27. Gottardi R, Wild C. Minimal-invasiver perkutaner Aortenklappenersatz (mit Exkurs zu Hybrid-OPs). Ludwig Boltzmann Institut Health Technology Assessment, 2011 06/04/2017. Report No.: 18. Available from: http://eprints.hta.lbg.ac.at/923/, S 1–31 Pschyrembel W. Pschyrembel Klinisches Wörterbuch 2013. 264., überarb. Aufl. ed. Berlin [u. a.]: De Gruyter, Berlin. 2012; 2311p. Bonow RO, Carabello BA, Kanu C (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Available via http://circ.ahajournals.org/content/114/5/e84. Cited 6 Juli 2017 Walther T, Blumenstein J, van Linden A, et al. Contemporary management of aortic stenosis: surgical aortic valve replacement remains the gold standard. Heart. 2012;98:23–9. Dimarakis I, Rehman SM, Grant SW, et al. Conventional aortic valve replacement for high-risk aortic stenosis patients not suitable for transcatheter aortic valve implantation: feasibility and outcome. Eur J Cardiothorac Surg. 2010;40(3):743–8. Kularatna S, Byrnes J, Mervin MC, et al. Health Technology Assessments Reporting Cost-Effectiveness of Transcatheter Aortic Valve Implantation. Int J Technol Assess Health Care. 2016;32(3):89–96. Genereux P, Head SJ, Wood DA, et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J. 2012;33(19):2388–98. Edwards Lifesciences Inc. (2017) Edwards SAPIEN valve. Available via http://www.edwards.com/de/devices/heart-valves/transcatheter. Cited 26 Juli 2017 Medtronic Inc. (2017) Heart Valves—Transcatheter. Available via http://www.medtronic.com/us-en/healthcare-professionals/products/cardiovascular/heart-valves-transcatheter.html. Cited 26 Juli 2017 Leon MB, Smith C, Mack M. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607. Smith C, Leon MB, Mack M, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98. Mack M, Leon MB, Smith C, et al. 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): A randomised controlled trial. Lancet. 2015;385(9986):2477–84. Arnold S, Reynolds MR, Wang KP, et al. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial. Cardiovasc Interv. 2015;8(9):1207–17. Tarricone R, Callea G, Ogorevc M, et al. Improving the Methods for the Economic Evaluation of Medical Devices. Health Econ. 2017;26(Suppl 1):70–92. Mühlberger V, Kaltenbach L. Herzkathetereingriffe in Österreich im Jahr 2015 (mit Audit bis 2016). Journal für Kardiologie. 2017;24((1–2)):7–12. Drummond M, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes, 3rd ed. Epidemiol Community Health2005. Campbell and Cochrane Economics Methods Group, Evidence for Policy and Practice Information and Coordinating Centre (2016) CCEMG—EPPI-Centre Cost Converter. Available via http://eppi.ioe.ac.uk/costconversion/default.aspx. Cited 2 Aug 2017 International Society for Pharmacoeconomics and Outcomes Research. Assessing the Evidence for Health Care Decision Makers Checklist. Available via https://www.healthstudyassessment.org/. Cited. Juli, Bd. 2017. 2017. World Health Organization (1998) WHO-CHOICE: Chosing interventions that are cost-effective. Genf. Available via http://www.who.int/choice/cost-effectiveness/en/. Cited 2018/24/05. Gada H, Kapadia SR, Tuzcu EM, et al. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol. 2012;109(9:1326–33. Gada H, Agarwal S, Marwick TH. Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model. Ann. 2012;1(2):145–55. Hancock-Howard RL, Feindel CM, Rodes-Cabau J, et al. Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings. J Med Econ. 2013;16(4):566–74. Freeman PM, Protty MB, Aldalati O, et al. Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)-a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data. Open. Heart. 2016;3(1):e414. Neyt M, Van Brabandt H, Devriese S, et al. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open. 2012;2(3). https://doi.org/10.1136/bmjopen-2012-001032 Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012;125(9):1102–9. Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart. 2012;98(5):370–6. Doble B, Blackhouse G, Goeree R, et al. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg. 2013;146(1):52–60.e3. Murphy A, Fenwick E, Toff WD, et al. Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom.[Erratum appears in Int J Technol Assess Health Care.2013 Jan;29(1):112]. Int J Technol Assess Health Care. 2013;29(1):12–9. Simons CT, Cipriano LE, Shah RU, et al. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2013;6(4):419–28. Brecker S, Mealing S, Padhiar A, et al. Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open. Heart. 2014;1(1):e155. Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60(25):2683–92. Fairbairn TA, Meads DM, Hulme C, et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart. 2013;99(13):914–20. Ribera A, Slof J, Andrea R, et al. Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants. Int J Cardiol. 2015;182:321–8. Reynolds MR, Lei Y, Wang K, et al. Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement. J Am Coll Cardiol. 2016;67(1):29–38. SpringerMedizin (2009) In Belgien wird der Patient sofort zur Kassa gebeten Available via http://www.springermedizin.at/artikel/2331-in-belgien-wird-der-patient-sofort-zur-kassa-gebeten. Cited 14 Aug 2017 Osnabrugge RLJ, Kappetein AP, Reynolds MR, et al. Cost-effectiveness of transcatheter valvular interventions: economic challenges. EuroIntervention. 2013;9(Suppl):S48–54. Eaton J, Mealing S, Thompson J, et al. Is transcatheter aortic valve implantation (TAVI) a cost-effective treatment in patients who are ineligible for surgical aortic valve replacement? A systematic review of economic evaluations. J Med Econ. 2014;17(5):365–75. Malaisrie SC. Is transcatheter aortic valve implantation cost effective in the nonsurgical elderly population? Interventional Cardiology (London). Acta Neurochir (Wien). 2013;5(4):411:8. Indraratna P, Ang SC, Gada H, et al. Systematic review of the cost-effectiveness of transcatheter aortic valve implantation. J Thorac Cardiovasc Surg. 2014;148(2):509–14. Iannaccone A, Marwick TH. Cost effectiveness of transcatheter aortic valve replacement compared with medical management or surgery for patients with aortic stenosis. Appl Health Econ Health Policy. 2015;13(1):29–45. Overbeck P. Transkatheter Aortenklappen – Auf dem Weg zu neuen Zielgruppen 2017/07/27. Available from: https://www.kardiologie.org/transkatheter-aortenklappen-auf-dem-weg-zu-neuen-zielgruppen/7138534. Brecker S, Aldea GS. Choice of therapy for symptomatic severe aortic stenosis. In: Cutlip D, Hrsg. UpToDate. 2017. Nixon J, Khan KS, Kleijnen J. Summarising economic evaluations in systematic reviews: a new approach. BMJ. Online. 2001;322(7302):1596–8. Heinzelmann UM. Beurteilung und Bedeutung des EuroSCORE-Systems in Bezug auf seine Anwendbarkeit im Klinikalltag [Dissertation]: Eberhard Karls Universität Tübingen; 2016. Available from: https://publikationen.unituebingen.de/xmlui/bitstream/handle/10900/71905/DISS_UH_EuroSCORE_2016.pdf?sequence=1&isAllowed=y (Unpublizierte Quelle)